These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35152319)

  • 1. Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections.
    Askari P; Yousefi M; Foadoddini M; Neshani A; Aganj M; Lotfi N; Movaqar A; Ghazvini K; Namaei MH
    Curr Microbiol; 2022 Feb; 79(4):102. PubMed ID: 35152319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?
    Lewies A; Du Plessis LH; Wentzel JF
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):370-381. PubMed ID: 30229514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections.
    Zhu Y; Hao W; Wang X; Ouyang J; Deng X; Yu H; Wang Y
    Med Res Rev; 2022 Jul; 42(4):1377-1422. PubMed ID: 34984699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary constraints on the acquisition of antimicrobial peptide resistance in bacterial pathogens.
    Jangir PK; Ogunlana L; MacLean RC
    Trends Microbiol; 2021 Dec; 29(12):1058-1061. PubMed ID: 33836929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides for combating drug-resistant bacterial infections.
    Xuan J; Feng W; Wang J; Wang R; Zhang B; Bo L; Chen ZS; Yang H; Sun L
    Drug Resist Updat; 2023 May; 68():100954. PubMed ID: 36905712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds.
    Erdem Büyükkiraz M; Kesmen Z
    J Appl Microbiol; 2022 Mar; 132(3):1573-1596. PubMed ID: 34606679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
    Li J; Fernández-Millán P; Boix E
    Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Peptides and Macromolecules for Combating Microbial Infections: From Agents to Interfaces.
    Yu L; Li K; Zhang J; Jin H; Saleem A; Song Q; Jia Q; Li P
    ACS Appl Bio Mater; 2022 Feb; 5(2):366-393. PubMed ID: 35072444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial peptides - Unleashing their therapeutic potential using nanotechnology.
    Gera S; Kankuri E; Kogermann K
    Pharmacol Ther; 2022 Apr; 232():107990. PubMed ID: 34592202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria.
    Mba IE; Nweze EI
    Yale J Biol Med; 2022 Dec; 95(4):445-463. PubMed ID: 36568838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Peptides and Cationic Nanoparticles: A Broad-Spectrum Weapon to Fight Multi-Drug Resistance Not Only in Bacteria.
    Valenti GE; Alfei S; Caviglia D; Domenicotti C; Marengo B
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics.
    Yu G; Baeder DY; Regoes RR; Rolff J
    Proc Biol Sci; 2018 Mar; 285(1874):. PubMed ID: 29540517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptides properties beyond growth inhibition and bacterial killing.
    Castillo-Juárez I; Blancas-Luciano BE; García-Contreras R; Fernández-Presas AM
    PeerJ; 2022; 10():e12667. PubMed ID: 35116194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review.
    Bugli F; Martini C; Di Vito M; Cacaci M; Catalucci D; Gori A; Iafisco M; Sanguinetti M; Vitali A
    Microbiol Res; 2022 Oct; 263():127152. PubMed ID: 35944357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides as a therapeutic strategy against Klebsiella pneumoniae.
    de Souza CM; da Silva ÁP; Júnior NGO; Martínez OF; Franco OL
    Trends Pharmacol Sci; 2022 Apr; 43(4):335-348. PubMed ID: 35078644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities.
    Luo Y; Song Y
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-helical cationic antimicrobial peptides: relationships of structure and function.
    Huang Y; Huang J; Chen Y
    Protein Cell; 2010 Feb; 1(2):143-52. PubMed ID: 21203984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
    Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
    Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and consequences of bacterial resistance to antimicrobial peptides.
    Andersson DI; Hughes D; Kubicek-Sutherland JZ
    Drug Resist Updat; 2016 May; 26():43-57. PubMed ID: 27180309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.